The cornea, as a dynamic and responsive tissue, constantly interacts with mechanical forces
in order to maintain its structural integrity, barrier function, transparency and refractive …

ROCK inhibitors are revolutionizing the subspecialty of cornea, and further research is
needed to compare long-term outcomes of ROCK inhibitor therapy to those of conventional …

Purpose: To investigate corneal clearance time using a topical rho-kinase inhibitor,
netarsudil, after descemetorhexis without endothelial keratoplasty (DWEK). Methods: Twenty …

Currently, there are very few well-established treatments to stimulate corneal endothelial cell
regeneration in vivo as a cure for corneal endothelial dysfunctions. The most frequently …

Rho kinase (ROCK) inhibitors have emerged as a key therapeutic class of interest in
ophthalmology over the last decade. Promising in vitro studies laid the foundations for the …

Purpose: To describe cases in which netarsudil ophthalmic solution 0.02% precipitated
reversible, reticular cystic epithelial edema. Methods: A retrospective case review at the …

Purpose Rho-associated kinase (ROCK) inhibitors have been successfully used as a rescue
strategy in eyes that failed to clear after descemetorhexis without endothelial graft for …

Purpose To describe 8 cases of reversible reticular corneal epithelial edema of the cornea
that developed after use of the topical Rho-kinase inhibitor netarsudil. Methods This is a …

Abstract Descemet's membrane (DM), the basement membrane of the corneal endothelium,
is formed from the extracellular matrix (ECM) secreted by corneal endothelial cells. The ECM …

Rho kinase (ROCK) inhibitors have gained significant attention as emerging novel treatment
options in the field of ophthalmology in recent years. The evidence supporting their efficacy …